Durham, North Carolina 27705

  • Depressive Symptoms


This double-blind placebo-controlled trial is designed to test and to compare the cardiovascular profile of paroxetine controlled release (CR) with duloxetine in outpatients with depressive symptoms.

Study summary:

This double-blind placebo-controlled study will test the hypothesis that greater reduction in heart rate variability will be associated with duloxetine than paroxetine in outpatients with major depressive disorder. We will also examine the relationship between changes in heart rate variability to the magnitude of serotonin and norepinephrine transporter occupancy produced by each drug.


Inclusion Criteria: - Depressive symptoms - Ages 20-60 - In good medical health and not pregnant Exclusion Criteria: - Bipolar disorder - Schizophrenia or other psychotic disorder - Alcohol or other substance abuse within the last 3 months - Cognitive impairment - History of attempted suicide in the past 2 months and who score 4 or more on the suicide item of the MADRS



Primary Contact:

Principal Investigator
Wei Zhang, M.D., Ph.D.
Duke University

Backup Contact:


Location Contact:

Durham, North Carolina 27705
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.